• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种简单的血管纤溶酶原激活剂定量测定法——不仅刺激的纤溶活性,而且基础纤溶活性都与静脉纤溶活性相关。

A simple quantitative assay of vascular plasminogen activator--not only stimulated fibrinolytic activity but also basal fibrinolytic activity are correlated with venous fibrinolytic activity.

作者信息

Hong S Y, Lee C S

机构信息

Department of Internal Medicine, Soonchunhyang University Chunan Hospital, Korea.

出版信息

Korean J Intern Med. 1990 Jul;5(2):87-92. doi: 10.3904/kjim.1990.5.2.87.

DOI:10.3904/kjim.1990.5.2.87
PMID:2098097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4535007/
Abstract

A simple method for the quantitative assay of vascular plasminogen activator is described. From 24 chronic renal failure patients who were undergoing surgery for A/V fistular or shunt construction, small pieces of artery (mean 7.8 mg, range 3.0-18.5 mg) and vein (mean 4.5 mg, range 3.0-8.8 mg) were used. The fibrinolytic activity was assayed on a well-controlled fibrin plate by only distilled water immersion and incubation at 37 degrees C. Basal fibrinolytic activity was correlated with venous fibrinolytic activity (r = 0.773, p less than 0.0001) and with arterial fibrinolytic activity (r = 0.55, 0.005 less than p less than 0.01). The increment of fibrinolytic activity by venous occlusion was correlated to venous fibrinolytic activity (r = 0.849, p less than 0.0001) but not to arterial fibrinolytic activity (r = 0.34, 0.1 less than p less than 0.25).

摘要

本文描述了一种定量检测血管纤溶酶原激活剂的简单方法。选取24例因动静脉内瘘或分流术而接受手术的慢性肾衰竭患者,取小块动脉组织(平均7.8mg,范围3.0 - 18.5mg)和静脉组织(平均4.5mg,范围3.0 - 8.8mg)。仅通过蒸馏水浸泡并在37℃孵育,在严格控制的纤维蛋白平板上检测纤溶活性。基础纤溶活性与静脉纤溶活性相关(r = 0.773,p < 0.0001),与动脉纤溶活性相关(r = 0.55,0.005 < p < 0.01)。静脉阻塞后纤溶活性的增加与静脉纤溶活性相关(r = 0.849,p < 0.0001),但与动脉纤溶活性无关(r = 0.34,0.1 < p < 0.25)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ab1/4535007/911c3e28fbc5/kjim-5-2-87-2f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ab1/4535007/3c131021c711/kjim-5-2-87-2f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ab1/4535007/c446e914506f/kjim-5-2-87-2f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ab1/4535007/96a72463634d/kjim-5-2-87-2f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ab1/4535007/911c3e28fbc5/kjim-5-2-87-2f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ab1/4535007/3c131021c711/kjim-5-2-87-2f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ab1/4535007/c446e914506f/kjim-5-2-87-2f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ab1/4535007/96a72463634d/kjim-5-2-87-2f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ab1/4535007/911c3e28fbc5/kjim-5-2-87-2f4.jpg

相似文献

1
A simple quantitative assay of vascular plasminogen activator--not only stimulated fibrinolytic activity but also basal fibrinolytic activity are correlated with venous fibrinolytic activity.一种简单的血管纤溶酶原激活剂定量测定法——不仅刺激的纤溶活性,而且基础纤溶活性都与静脉纤溶活性相关。
Korean J Intern Med. 1990 Jul;5(2):87-92. doi: 10.3904/kjim.1990.5.2.87.
2
Residual plasminogen activator inhibitor activity after venous stasis as a criterion for hypofibrinolysis: a study in 83 patients with confirmed deep vein thrombosis.静脉淤滞后残余纤溶酶原激活物抑制剂活性作为低纤溶的标准:对83例确诊深静脉血栓形成患者的研究
Blood. 1988 Aug;72(2):601-5.
3
A simple spectrophotometric assay of plasminogen activator: comparison with the fibrinolytic method.
Clin Chim Acta. 1984 Aug 31;141(2-3):101-9. doi: 10.1016/0009-8981(84)90002-0.
4
Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays.采用纤维蛋白和非纤维蛋白检测法测定人肿瘤组织及相邻正常组织中的纤溶酶原激活物含量。
Cancer Res. 1986 Apr;46(4 Pt 1):1788-94.
5
Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.青少年血液纤溶成分的年龄依赖性以及低剂量口服避孕药对青少年凝血和纤溶的影响。
Thromb Haemost. 1988 Dec 22;60(3):361-4.
6
Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.正常受试者的纤维蛋白溶解——纤溶酶原激活物抑制剂与纤维蛋白溶解系统其他成分的比较
Thromb Haemost. 1988 Apr 8;59(2):299-303.
7
Fibrinolytic activity in renal venous blood in man.人体肾静脉血中的纤溶活性。
Klin Wochenschr. 1986 Jul 1;64(13):587-9. doi: 10.1007/BF01735260.
8
Response of fibrinolytic activity to venous occlusion.纤溶活性对静脉闭塞的反应。
Br Med J. 1975 Sep 6;3(5983):571-3. doi: 10.1136/bmj.3.5983.571.
9
Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.健康与疾病中的纤维蛋白溶解:系统性红斑狼疮中的严重异常
J Lab Clin Med. 1984 Dec;104(6):962-76.
10
Neurovascular fibrinolytic activity in normal Lewis rats and rats with cell-transferred experimental allergic encephalomyelitis.正常Lewis大鼠和细胞移植实验性变态反应性脑脊髓炎大鼠的神经血管纤溶活性
J Neuroimmunol. 1990 Aug;28(3):189-200. doi: 10.1016/0165-5728(90)90012-c.

本文引用的文献

1
The fibrinolytic activator in animal tissue.动物组织中的纤溶激活剂。
Acta Physiol Scand. 1950 Nov;21(2-3):159-67. doi: 10.1111/j.1748-1716.1950.tb00723.x.
2
INCREASE IN FIBRINOLYTIC ACTIVITY BY VENOUS OCCLUSION.静脉阻塞导致纤溶活性增加。
J Appl Physiol. 1963 Nov;18:1123-9. doi: 10.1152/jappl.1963.18.6.1123.
3
The histological localisation of fibrinolysin activator.纤维蛋白溶酶激活剂的组织学定位。
J Pathol Bacteriol. 1959 Jul;78:281-3. doi: 10.1002/path.1700780131.
4
Induction of fibrinolysis by venous obstruction.
Angiology. 1960 Oct;11:367-70. doi: 10.1177/000331976001100501.
5
Fibrinolysis autographs.纤维蛋白溶解图谱
Nature. 1958 Feb 15;181(4607):495-6. doi: 10.1038/181495b0.
6
Estimation of the plasminogen activator and the trypsin inhibitor in animal and human tissues.动物和人体组织中纤溶酶原激活剂及胰蛋白酶抑制剂的测定。
Scand J Clin Lab Invest. 1957;9(3):233-43. doi: 10.3109/00365515709079963.
7
Heat denaturation of plasminogen in the fibrin plate method.纤维蛋白平板法中纤溶酶原的热变性
Acta Physiol Scand. 1953 Feb 28;27(4):371-6. doi: 10.1111/j.1748-1716.1953.tb00951.x.
8
Comparison between the plasminogen activator activity in walls of superficial, muscle and deep veins.浅静脉、肌静脉和深静脉壁中纤溶酶原激活物活性的比较。
Thromb Res. 1981 May 1;22(3):295-302. doi: 10.1016/0049-3848(81)90122-5.
9
Relationship between tissue plasminogen activator and the activators in blood and vascular wall.组织型纤溶酶原激活剂与血液及血管壁中的激活剂之间的关系。
Thromb Res. 1980 Jun 15;18(6):815-30. doi: 10.1016/0049-3848(80)90204-2.
10
Comparison of the plasminogen activator activity of superficial hand and foot veins.手足浅表静脉纤溶酶原激活物活性的比较
Thromb Res. 1982 Dec 1;28(5):617-23. doi: 10.1016/0049-3848(82)90153-0.